Penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effect on susceptibility categorisation in Germany (1997–2013)

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 11, 2014, Pages 2035-2040

  Imohl M ^a   Reinert, R R ^a,b   Tulkens, P M ^c   van der Linden, M ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b PFIZER INC   (United States)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN DERIVATIVE; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; GERMANY; GROUP B STREPTOCOCCAL MENINGITIS; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PRACTICE GUIDELINE; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PNEUMOCOCCAL INFECTION; PREVALENCE; STANDARDS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; GERMANY; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLINS; PNEUMOCOCCAL INFECTIONS; PREVALENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 84911007462     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2174-z     Document Type: Article

References (30)

1. Austrian R (1981) Pneumococcus: the first one hundred years. Rev Infect Dis 3(2):183–189
2. Clinical Laboratory Standards Institute (CLSI) (2006) Performance standards for antimicrobial susceptibility testing; 16th informational supplement. CLSI document M100-S16. CLSI, Wayne, PA
3. Clinical Laboratory Standards Institute (CLSI) (2008) Performance standards for antimicrobial susceptibility testing; 18th informational supplement. CLSI document M100-S18. CLSI, Wayne, PA
4. Clinical Laboratory Standards Institute (CLSI) (2014) Performance standards for antimicrobial susceptibility testing; 24th informational supplement. CLSI document M100-S24. CLSI, Wayne, PA
5. Centers for Disease Control and Prevention (CDC) (2008) Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae—United States, 2006–2007. MMWR Morb Mortal Wkly Rep 57(50):1353–1355
6. Weinstein MP, Klugman KP, Jones RN (2009) Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance. Clin Infect Dis 48(11):1596–1600
7. European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2009) Breakpoint tables for interpretation of MICs and zone diameters, version 1.0, December 2009. European Society of Clinical Microbiology and Infectious Diseases (ESCMID). http://www.eucast.org
8. European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2014) Breakpoint tables for interpretation of MICs and zone diameters, version 4.0, January 2014. European Society of Clinical Microbiology and Infectious Diseases (ESCMID). http://www.eucast.org
9. Imöhl M, Reinert RR, van der Linden M (2009) New penicillin susceptibility breakpoints for streptococcus pneumoniae and their effects on susceptibility categorisation in Germany (1992–2008). Int J Antimicrob Agents 34(3):271–273
10. Jacobs MR, Good CE, Beall B, Bajaksouzian S, Windau AR, Whitney CG (2008) Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience. J Clin Microbiol 46(3):982–990
11. Livermore DM (2003) Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis 36(Suppl 1):S11–S23
12. Reinert RR (2004) Pneumococcal conjugate vaccines—a European perspective. Int J Med Microbiol 294(5):277–294
13. Pérez-Trallero E, Martín-Herrero JE, Mazón A, García-Delafuente C, Robles P, Iriarte V, Dal-Ré R, García-de-Lomas J; Spanish Surveillance Group for Respiratory Pathogens (2010) Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996–1997 to 2006–2007). Antimicrob Agents Chemother 54(7):2953–2959
14. Fenoll A, Granizo JJ, Aguilar L, Giménez MJ, Aragoneses-Fenoll L, Hanquet G, Casal J, Tarragó D (2009) Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol 47(4):1012–1020
15. Su LH, Wu TL, Kuo AJ, Chia JH, Chiu CH (2009) Antimicrobial susceptibility of Streptococcus pneumoniae at a university hospital in Taiwan, 2000–07: impact of modified non-meningeal penicillin breakpoints in CLSI M100-S18. J Antimicrob Chemother 64(2):336–342
16. Oteo J, Lázaro E, de Abajo FJ, Baquero F, Campos J; Spanish Members of the European Antimicrobial Resistance Surveillance System (2004) Trends in antimicrobial resistance in 1,968 invasive Streptococcus pneumoniae strains isolated in Spanish hospitals (2001 to 2003): decreasing penicillin resistance in children’s isolates. J Clin Microbiol 42(12):5571–5577
17. Goossens MC, Catry B, Verhaegen J (2013) Antimicrobial resistance to benzylpenicillin in invasive pneumococcal disease in Belgium, 2003–2010: the effect of altering clinical breakpoints. Epidemiol Infect 141(3):490–495
18. Song JH (2013) Advances in pneumococcal antibiotic resistance. Expert Rev Respir Med 7(5):491–498
19. Doğan O, Gülmez D, Hasçelik G (2010) Effect of new breakpoints proposed by Clinical and Laboratory Standards Institute in 2008 for evaluating penicillin resistance of Streptococcus pneumoniae in a Turkish University Hospital. Microb Drug Resist 16(1):39–41
20. Wolkers PC, Mantese OC, Paula A, Almeida VV, Aguiar PA, Alvares JR, Almeida SC, Brandileone MC (2009) New susceptibility breakpoints in antimicrobial resistance rates of invasive pneumococcal strains. J Pediatr (Rio J) 85(5):421–425
21. Jacobs MR (2007) Clinical significance of antimicrobial resistance in Streptococcus pneumoniae. S Afr Med J 97(11 Pt 3):1133–1140
22. Mera RM, Miller LA, Amrine-Madsen H, Sahm DF (2011) Impact of new Clinical Laboratory Standards Institute Streptococcus pneumoniae penicillin susceptibility testing breakpoints on reported resistance changes over time. Microb Drug Resist 17(1):47–52
23. Imöhl M, Reinert RR, van der Linden M (2010) Serotype-specific penicillin resistance of Streptococcus pneumoniae in Germany from 1992 to 2008. Int J Med Microbiol 300(5):324–330
24. Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, Facklam RR, Jorgensen JH, Besser J, Zell ER, Schuchat A, Whitney CG; Active Bacterial Core Surveillance of the Emerging Infections Program Network (2006) Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354(14):1455–1463
25. Hammitt LL, Bruden DL, Butler JC, Baggett HC, Hurlburt DA, Reasonover A, Hennessy TW (2006) Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. J Infect Dis 193(11):1487–1494
26. Dagan R, Klugman KP (2008) Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis 8(12):785–795
27. Imöhl M, Reinert RR, van der Linden M (2010) Temporal variations among invasive pneumococcal disease serotypes in children and adults in Germany (1992–2008). Int J Microbiol 2010:874189
28. Feikin DR, Klugman KP (2002) Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines. Clin Infect Dis 35(5):547–555
29. Imöhl M, Reinert RR, van der Linden M (2010) Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states. Int J Med Microbiol 300(4):237–247
30. Feikin DR, Klugman KP, Facklam RR, Zell ER, Schuchat A, Whitney CG; Active Bacterial Core surveillance/Emerging Infections Program Network (2005) Increased prevalence of pediatric pneumococcal serotypes in elderly adults. Clin Infect Dis 41(4):481–487